搜尋結果
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for ...
Bastillepost· 2 日前ImmunityBio, Inc. ( NASDAQ: IBRX ), an immunotherapy company, today announced that the U.S. ...
Short sellers pocket record weekly profit from Big Tech selloff
Reuters· 2 日前Traders who bet against the "Magnificent 7" group of big U.S. tech stocks booked ...
Prehistoric lake sturgeon is not endangered, US says despite calls from conservationists
Bastillepost· 2 日前Lake sturgeon don't need Endangered Species Act protections, federal wildlife officials ...
Policies can create growth momentum
China Daily· 2 日前Foreign investments have had a long history of facilitating industrialization in China. In the early 1980s, China expanded ...
Rethinking value in Hong Kong's materialistic society - Dimsum Daily
Dimsum Daily· 2 日前22nd April 2024 – (Hong Kong) In the heart of Hong Kong, a city often characterised by its relentless pursuit of luxury ...
By 2100, Some Destinations Will Lose Half Their Nice Weather Days
Bloomberg· 2 日前The Dominican Republic, known for good weather, will have 124 fewer “outdoor days” in 75 years ...
Does An Ivy League Degree Matter?
Forbes· 3 日前As May 1, the national college admission deadline for seniors to submit their enrollment ...
How To Utilize Life Insurance For Retirement Income
Forbes· 3 日前Life insurance should be a part of many people's retirement plans. Keep reading as we share ...
Council Post: The Power Of Establishing A Decision Cadence For Business Success
Forbes· 3 日前How leaders make decisions can have far-reaching organizational implications, especially when ...
Disney Faces Backlash Over Theme Park Disability Access Changes
Forbes· 3 日前Disney has come under fire from a coalition representing guests with disabilities planning to ...